Nature cancer

Keyphrases

Publications

volume 5, number 6, 2024

Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, Ashwin V Kammula, Saugato Rahman Dhruba, Wei Wu, D Lucas Kerr, Nishanth Ulhas Nair, Matthew G Jones, Nir Yosef, Oleg V Stroganov, Ivan Grishagin, Kenneth D Aldape, Collin M Blakely, Peng Jiang, Craig J Thomas, Cyril H Benes, Trever G Bivona, Alejandro A Schäffer, Eytan Ruppin
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nature cancer 5 (6) (2024)
Darragh Flood, Cormac T Taylor
Targeting HIF-1 to treat AML. Nature cancer 5 (6) (2024)
Hannah Lawson, James P Holt-Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N van de Lagemaat, Azzura L De Pace, Anthony Tumber, Thomas P Corner, Eidarus Salah, Christine Arndt, Lennart Brewitz, Matthew J Bowen, Louis Dubusse, Derek George, Lewis Allen, Amélie Valérie Guitart, Tsz Kan Fung, Chi Wai Eric So, Juerg Schwaller, Paolo Gallipoli, Donal O'Carroll, Christopher J Schofield, Kamil R Kranc
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. Nature cancer 5 (6) (2024)

volume 5, number 7, 2024

Xiangyu Chen, Jing Zhao, Shuai Yue, Ziyu Li, Xiang Duan, Yao Lin, Yang Yang, Junjian He, Leiqiong Gao, Zhiwei Pan, Xiaofan Yang, Xingxing Su, Min Huang, Xiao Li, Ye Zhao, Xuehui Zhang, Zhirong Li, Li Hu, Jianfang Tang, Yaxing Hao, Qin Tian, Yifei Wang, Lifan Xu, Qizhao Huang, Yingjiao Cao, Yaokai Chen, Bo Zhu, Yan Li, Fan Bai, Guo-Zhong Zhang, Lilin Ye
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy. Nature cancer 5 (7) (2024)
Kevin M Tharp, Kelly Kersten, Ori Maller, Greg A Timblin, Connor Stashko, Fernando P Canale, Rosa E Menjivar, Mary-Kate Hayward, Ilona Berestjuk, Johanna Ten Hoeve, Bushra Samad, Alastrair J Ironside, Marina Pasca Di Magliano, Alexander Muir, Roger Geiger, Alexis J Combes, Valerie M Weaver
Tumor-associated macrophages restrict CD8 + T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nature cancer 5 (7) (2024)
Lois M Kelly, Justine C Rutter, Kevin H Lin, Frank Ling, Matthieu Duchmann, Emmanuelle Latour, Nadia Arang, Hélène Pasquer, Duong Ho Nhat, Juliette Charles, Shane T Killarney, Hazel Xiaohui Ang, Federica Namor, Cécile Culeux, Berangere Lombard, Damarys Loew, Danielle L Swaney, Nevan J Krogan, Luc Brunel, Élodie Carretero, Pascal Verdié, Muriel Amblard, Sofiane Fodil, Tony Huynh, Marie Sébert, Lionel Ades, Emmanuel Raffoux, Nina Fenouille, Raphaël A Itzykson, Camille Lobry, Lina Benajiba, Antoine Forget, Anthony R Martin, Kris C Wood, Alexandre Puissant
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule. Nature cancer 5 (7) (2024)
Emilie A Chapeau, Laurent Sansregret, Giorgio Giacomo Galli, Patrick Chène, Markus Wartmann, Thanos P Mourikis, Patricia Jaaks, Sabrina Baltschukat, Ines A M Barbosa, Daniel Bauer, Saskia M Brachmann, Clara Delaunay, Claire Estadieu, Jason E Faris, Pascal Furet, Stefanie Harlfinger, Andreas Hueber, Eloísa Jiménez Núñez, David P Kodack, Emeline Mandon, Typhaine Martin, Yannick Mesrouze, Vincent Romanet, Clemens Scheufler, Holger Sellner, Christelle Stamm, Dario Sterker, Luca Tordella, Francesco Hofmann, Nicolas Soldermann, Tobias Schmelzle
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nature cancer 5 (7) (2024)
Emilie A Chapeau, Laurent Sansregret, Giorgio Giacomo Galli, Patrick Chène, Markus Wartmann, Thanos P Mourikis, Patricia Jaaks, Sabrina Baltschukat, Ines A M Barbosa, Daniel Bauer, Saskia M Brachmann, Clara Delaunay, Claire Estadieu, Jason E Faris, Pascal Furet, Stefanie Harlfinger, Andreas Hueber, Eloísa Jiménez Núñez, David P Kodack, Emeline Mandon, Typhaine Martin, Yannick Mesrouze, Vincent Romanet, Clemens Scheufler, Holger Sellner, Christelle Stamm, Dario Sterker, Luca Tordella, Francesco Hofmann, Nicolas Soldermann, Tobias Schmelzle
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nature cancer 5 (7) (2024)
Sungjoon Park, Erica Silva, Akshat Singhal, Marcus R Kelly, Kate Licon, Isabella Panagiotou, Catalina Fogg, Samson Fong, John J Y Lee, Xiaoyu Zhao, Robin E Bachelder, Barbara A Parker, Kay T Yeung, Trey Ideker
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nature cancer 5 (7) (2024)
Bailey M Robertson, Mitchell E Fane, Ashani T Weeraratna, Vito W Rebecca
Determinants of resistance and response to melanoma therapy. Nature cancer 5 (7) (2024)
Xiangyu Chen, Jing Zhao, Shuai Yue, Ziyu Li, Xiang Duan, Yao Lin, Yang Yang, Junjian He, Leiqiong Gao, Zhiwei Pan, Xiaofan Yang, Xingxing Su, Min Huang, Xiao Li, Ye Zhao, Xuehui Zhang, Zhirong Li, Li Hu, Jianfang Tang, Yaxing Hao, Qin Tian, Yifei Wang, Lifan Xu, Qizhao Huang, Yingjiao Cao, Yaokai Chen, Bo Zhu, Yan Li, Fan Bai, Guo-Zhong Zhang, Lilin Ye
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy. Nature cancer 5 (7) (2024)
Aaron J Stonestrom, Ross L Levine
Inhibiting PI3Kγ in acute myeloid leukemia. Nature cancer 5 (7) (2024)
Matthew D Perricone, Costas Andreas Lyssiotis
Fibrotic tumors tune metabolism for immune evasion. Nature cancer 5 (7) (2024)
Kevin M Tharp, Kelly Kersten, Ori Maller, Greg A Timblin, Connor Stashko, Fernando P Canale, Rosa E Menjivar, Mary-Kate Hayward, Ilona Berestjuk, Johanna Ten Hoeve, Bushra Samad, Alastrair J Ironside, Marina Pasca Di Magliano, Alexander Muir, Roger Geiger, Alexis J Combes, Valerie M Weaver
Tumor-associated macrophages restrict CD8 + T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nature cancer 5 (7) (2024)
Xiangyu Chen, Jing Zhao, Shuai Yue, Ziyu Li, Xiang Duan, Yao Lin, Yang Yang, Junjian He, Leiqiong Gao, Zhiwei Pan, Xiaofan Yang, Xingxing Su, Min Huang, Xiao Li, Ye Zhao, Xuehui Zhang, Zhirong Li, Li Hu, Jianfang Tang, Yaxing Hao, Qin Tian, Yifei Wang, Lifan Xu, Qizhao Huang, Yingjiao Cao, Yaokai Chen, Bo Zhu, Yan Li, Fan Bai, Guo-Zhong Zhang, Lilin Ye
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy. Nature cancer 5 (7) (2024)
Kevin P Letscher, Sai T Reddy
Multidimensional analysis reveals predictive markers for CAR-T efficacy. Nature cancer 5 (7) (2024)
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, Darren Heeke, Melisa Martinez-Paniagua, Xingyue An, Irfan N Bandey, Melisa J Montalvo, Jay R T Adolacion, Arash Saeedi, Fatemeh Sadeghi, Kristen Fousek, Nahum Puebla-Osorio, Laurence J N Cooper, Chantale Bernatchez, Harjeet Singh, Nabil Ahmed, Mike Mattie, Adrian Bot, Sattva S Neelapu, Navin Varadarajan
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling. Nature cancer 5 (7) (2024)
Xujia Wu, Huairui Yuan, Qiulian Wu, Yixin Gao, Tingting Duan, Kailin Yang, Tengfei Huang, Shuai Wang, Fanen Yuan, Derrick Lee, Suchet Taori, Tritan Plute, Søren Heissel, Hanan Alwaseem, Michael Isay-Del Viscio, Henrik Molina, Sameer Agnihotri, Dennis J Hsu, Nu Zhang, Jeremy N Rich
Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming. Nature cancer 5 (7) (2024)
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S El-Deiry, Emmanuel S Antonarakis, Stephanie L Graff, Michael J Hall, Hossein Borghaei, Dave S B Hoon, Stephen V Liu, Patrick C Ma, Rana R McKay, Trisha Wise-Draper, John Marshall, George W Sledge, David Spetzler, Hao Zhu, David Hsiehchen
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature cancer 5 (7) (2024)
Sungjoon Park, Erica Silva, Akshat Singhal, Marcus R Kelly, Kate Licon, Isabella Panagiotou, Catalina Fogg, Samson Fong, John J Y Lee, Xiaoyu Zhao, Robin E Bachelder, Barbara A Parker, Kay T Yeung, Trey Ideker
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nature cancer 5 (7) (2024)
Gizem Efe, Anil K Rustgi, Carol Prives
p53 at the crossroads of tumor immunity. Nature cancer 5 (7) (2024)
Emilie A Chapeau, Laurent Sansregret, Giorgio Giacomo Galli, Patrick Chène, Markus Wartmann, Thanos P Mourikis, Patricia Jaaks, Sabrina Baltschukat, Ines A M Barbosa, Daniel Bauer, Saskia M Brachmann, Clara Delaunay, Claire Estadieu, Jason E Faris, Pascal Furet, Stefanie Harlfinger, Andreas Hueber, Eloísa Jiménez Núñez, David P Kodack, Emeline Mandon, Typhaine Martin, Yannick Mesrouze, Vincent Romanet, Clemens Scheufler, Holger Sellner, Christelle Stamm, Dario Sterker, Luca Tordella, Francesco Hofmann, Nicolas Soldermann, Tobias Schmelzle
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nature cancer 5 (7) (2024)

volume 5, number 8, 2024

Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer 5 (8) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
Marcel Arias-Badia, Ryan Chang, Lawrence Fong
γδ T cells as critical anti-tumor immune effectors. Nature cancer 5 (8) (2024)
Xu Shi, Christos Gekas, Daniel Verduzco, Sakina Petiwala, Cynthia Jeffries, Charles Lu, Erin Murphy, Tifani Anton, Andy H Vo, Zhiguang Xiao, Padmini Narayanan, Bee-Chun Sun, Aloma L D'Souza, J Matthew Barnes, Somdutta Roy, Cyril Ramathal, Michael J Flister, Zoltán Dezső
Building a translational cancer dependency map for The Cancer Genome Atlas. Nature cancer 5 (8) (2024)
Christopher E Whitehead, Elizabeth K Ziemke, Christy L Frankowski-McGregor, Rachel A Mumby, June Chung, Jinju Li, Nathaniel Osher, Oluwadara Coker, Veerabhadran Baladandayuthapani, Edmund S Kopetz, Judith S Sebolt-Leopold
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance. Nature cancer 5 (8) (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Anders Hofer
How tumors hijack macrophages for immune evasion. Nature cancer 5 (8) (2024)
Carmen van Dooijeweert, R N Flach, Natalie D Ter Hoeve, C P H Vreuls, R Goldschmeding, J E Freund, P Pham, T Q Nguyen, E van der Wall, G W J Frederix, Nikolas Stathonikos, Paul J van Diest
Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial. Nature cancer 5 (8) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Xu Shi, Christos Gekas, Daniel Verduzco, Sakina Petiwala, Cynthia Jeffries, Charles Lu, Erin Murphy, Tifani Anton, Andy H Vo, Zhiguang Xiao, Padmini Narayanan, Bee-Chun Sun, Aloma L D'Souza, J Matthew Barnes, Somdutta Roy, Cyril Ramathal, Michael J Flister, Zoltán Dezső
Building a translational cancer dependency map for The Cancer Genome Atlas. Nature cancer 5 (8) (2024)
Christopher E Whitehead, Elizabeth K Ziemke, Christy L Frankowski-McGregor, Rachel A Mumby, June Chung, Jinju Li, Nathaniel Osher, Oluwadara Coker, Veerabhadran Baladandayuthapani, Edmund S Kopetz, Judith S Sebolt-Leopold
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance. Nature cancer 5 (8) (2024)
Erik N Bergstrom, Ludmil B Alexandrov
Enhanced precision in immunotherapy. Nature cancer 5 (8) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Meghri Katerji, Maxine R Rubin, John Brognard
Dual inhibition of EGFR and PI3K with a single drug. Nature cancer 5 (8) (2024)
Carmen van Dooijeweert, R N Flach, Natalie D Ter Hoeve, C P H Vreuls, R Goldschmeding, J E Freund, P Pham, T Q Nguyen, E van der Wall, G W J Frederix, Nikolas Stathonikos, Paul J van Diest
Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial. Nature cancer 5 (8) (2024)
Carmen van Dooijeweert, R N Flach, Natalie D Ter Hoeve, C P H Vreuls, R Goldschmeding, J E Freund, P Pham, T Q Nguyen, E van der Wall, G W J Frederix, Nikolas Stathonikos, Paul J van Diest
Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial. Nature cancer 5 (8) (2024)
Anders Hofer
How tumors hijack macrophages for immune evasion. Nature cancer 5 (8) (2024)
Tommaso Scolaro, Marta Manco, Mathieu Pecqueux, Ricardo Amorim, Rosa Trotta, Heleen H Van Acker, Matthias Van Haele, Niranjan Shirgaonkar, Stefan Naulaerts, Jan Daniluk, Fran Prenen, Chiara Varamo, Donatella Ponti, Ginevra Doglioni, Ana Margarida Ferreira Campos, Juan Fernández-García, Silvia Radenkovic, Pegah Rouhi, Aleksandar Beatovic, Liwei Wang, Yu Wang, Amalia Tzoumpa, Asier Antoranz, Ara Sargsian, Mario Di Matteo, Emanuele Berardi, Jermaine Goveia, Bart Ghesquiere, Tania Roskams, Stefaan J Soenen, Thomas Voets, Bella Manshian, Sarah-Maria Fendt, Peter Carmeliet, Abhishek Dinkarnath Garg, Ramanuj DasGupta, Baki Topal, Massimilliano Mazzone
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nature cancer 5 (8) (2024)
Xu Shi, Christos Gekas, Daniel Verduzco, Sakina Petiwala, Cynthia Jeffries, Charles Lu, Erin Murphy, Tifani Anton, Andy H Vo, Zhiguang Xiao, Padmini Narayanan, Bee-Chun Sun, Aloma L D'Souza, J Matthew Barnes, Somdutta Roy, Cyril Ramathal, Michael J Flister, Zoltán Dezső
Building a translational cancer dependency map for The Cancer Genome Atlas. Nature cancer 5 (8) (2024)
Christopher E Whitehead, Elizabeth K Ziemke, Christy L Frankowski-McGregor, Rachel A Mumby, June Chung, Jinju Li, Nathaniel Osher, Oluwadara Coker, Veerabhadran Baladandayuthapani, Edmund S Kopetz, Judith S Sebolt-Leopold
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance. Nature cancer 5 (8) (2024)
Erik N Bergstrom, Ludmil B Alexandrov
Enhanced precision in immunotherapy. Nature cancer 5 (8) (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Marcel Arias-Badia, Ryan Chang, Lawrence Fong
γδ T cells as critical anti-tumor immune effectors. Nature cancer 5 (8) (2024)
Meghri Katerji, Maxine R Rubin, John Brognard
Dual inhibition of EGFR and PI3K with a single drug. Nature cancer 5 (8) (2024)
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger, Manuela Benary, Sina Müller, Xiang Gao, Arunima Murgai, Mohamed Haji, Annika Schmidt, Raphael Lutz, Axel Nogai, Jan Braune, Dominik Laue, Christian Langer, Cyrus Khandanpour, Florian Bassermann, Hartmut Döhner, Monika Engelhardt, Christian Straka, Michael Hundemer, Dieter Beule, Simon Haas, Ulrich Bernd Keller, Hermann Einsele, Lars Bullinger, Stefan Knop, Philipp Mertins, Jan Krönke
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities. Nature cancer 5 (8) (2024)
Marcel Arias-Badia, Ryan Chang, Lawrence Fong
γδ T cells as critical anti-tumor immune effectors. Nature cancer 5 (8) (2024)
Tian-Gen Chang, Yingying Cao, Hannah J Sfreddo, Saugato Rahman Dhruba, Se-Hoon Lee, Cristina Valero, Seong-Keun Yoo, Diego Chowell, Luc G T Morris, Eytan Ruppin
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features. Nature cancer 5 (8) (2024)